|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,550 KRW | -2.53% |
|
-0.76% | +7.38% |
Bukwang Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 149.84 million compared to KRW 202.44 million a year ago. Net loss was KRW 31,329.66 million compared to KRW 2,474.85 million a year ago.
Basic loss per share from continuing operations was KRW 458 compared to KRW 36 a year ago. Basic loss per share was KRW 458 compared to KRW 36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.38% | 331M | |
| +21.63% | 44.11B | |
| +23.03% | 22.71B | |
| +18.22% | 15.15B | |
| +12.66% | 13.56B | |
| +60.18% | 12.7B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.63B |
BUKWANG PHARMACEUTICAL CO., LTD. 
